Z, A. R., H, O., SH, Z., M, H., A, M., & B, S. (2025). The role of interleukin-37 and interleukin-38 in the development and remission of autism spectrum disorder: A comprehensive review of neuroinflammatory mechanisms and potential therapeutic implications. Frontiers in immunology, 16, 1716197. https://doi.org/10.3389/fimmu.2025.1716197
Chicago Style (17th ed.) CitationZ, Al Rasbi, Orsud H, Zoughbor SH, Hajar M, Mahboob A, and Sadek B. "The Role of Interleukin-37 and Interleukin-38 in the Development and Remission of Autism Spectrum Disorder: A Comprehensive Review of Neuroinflammatory Mechanisms and Potential Therapeutic Implications." Frontiers in Immunology 16 (2025): 1716197. https://doi.org/10.3389/fimmu.2025.1716197.
MLA (9th ed.) CitationZ, Al Rasbi, et al. "The Role of Interleukin-37 and Interleukin-38 in the Development and Remission of Autism Spectrum Disorder: A Comprehensive Review of Neuroinflammatory Mechanisms and Potential Therapeutic Implications." Frontiers in Immunology, vol. 16, 2025, p. 1716197, https://doi.org/10.3389/fimmu.2025.1716197.